Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study
A skin disorder within 30 days was a favorable prognostic factor for patients with LSCC administered Neci + GC. Additionally, minocycline administration may be beneficial in patients who develop skin disorders within 30 days.
Authors
- Takahisa Kawamura (ORCID: https://orcid.org/0000-0001-6611-659X)
- Satoshi Watanabe (ORCID: https://orcid.org/0000-0003-0041-6981)
- Fumihiko Kinoshita (ORCID: https://orcid.org/0000-0002-4557-0491)
- Anna Hayashi
- Kosuke Tsuruno (ORCID: https://orcid.org/0000-0002-2092-0846)
- Kazuhiro Asada
- Kiichiro Ninomiya (ORCID: https://orcid.org/0000-0002-2134-2865)
- Hiroshi Kuraishi
- Hisashi Tanaka (ORCID: https://orcid.org/0000-0003-2009-0210)
- Eisaku Miyauchi (ORCID: https://orcid.org/0000-0002-6837-6392)
- Akira Nakao (ORCID: https://orcid.org/0000-0001-8308-4227)
- Kakuhiro Yamaguchi (ORCID: https://orcid.org/0000-0002-9117-1934)
- Teppei Yamaguchi (ORCID: https://orcid.org/0000-0002-8909-5709)
- Toshihiro Misumi (ORCID: https://orcid.org/0000-0001-8339-2895)
- Hiroshi Tanaka (ORCID: https://orcid.org/0000-0001-7057-813X)
- Hiroshige Yoshioka (ORCID: https://orcid.org/0000-0001-7724-0481)
- Satoshi Tetsumoto
- Masafumi Yamaguchi (ORCID: https://orcid.org/0000-0002-2825-7217)
- Yosuke Kawashima (ORCID: https://orcid.org/0000-0002-9824-6572)
- Ken Yoshihara
- Shigeru Tanzawa (ORCID: https://orcid.org/0000-0001-5738-0313)
- Akihito Kubo (ORCID: https://orcid.org/0000-0001-9221-8880)
- Yuki Misumi (ORCID: https://orcid.org/0000-0001-9633-9268)
- Yasunori Murata
- Akihiko Miyanaga (ORCID: https://orcid.org/0000-0003-2026-9181)
- Toshihiko Yokoyama (ORCID: https://orcid.org/0000-0003-0161-7216)
- Shoichi Kuyama (ORCID: https://orcid.org/0000-0002-6079-3511)
- Yuki Sato (ORCID: https://orcid.org/0000-0003-2069-0355)
- Yukihiro Umeda (ORCID: https://orcid.org/0000-0002-9826-6856)
- Toshiyuki Kozuki (ORCID: https://orcid.org/0000-0001-8432-8975)
- Shunichi Sugawara (ORCID: https://orcid.org/0000-0002-3427-4558)
- Masafumi Nojiri
- Kazuki Hashimoto (ORCID: https://orcid.org/0000-0002-8324-2202)
- Ken Yamamoto (ORCID: https://orcid.org/0000-0002-1531-9685)
- Nobuhiko Seki (ORCID: https://orcid.org/0000-0002-0732-5348)
- Takuji Suzuki (ORCID: https://orcid.org/0000-0003-0416-6641)
- Ryoichi Honda
- Masahide Mori (ORCID: https://orcid.org/0009-0007-9223-3854)
- Ken Masuda (ORCID: https://orcid.org/0000-0002-7736-3737)
- Kana Watanabe (ORCID: https://orcid.org/0000-0001-5139-5901)
- Masafumi Takeshita
Institutions
- University of Fukui (JP)
- Kansai Medical University (JP)
- Hirosaki University (JP)
- Chiba University (JP)
- Aichi Medical University (JP)
- Kanazawa Medical University (JP)
- Shimane University (JP)
- Fukuoka University Hospital (JP)
- Niigata Cancer Center Hospital (JP)
- National Hospital Organization Kyushu Cancer Center (JP)
- Tohoku University Hospital (JP)
- Okayama University Hospital (JP)
- Toneyama National Hospital (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Hiroshima Prefectural Hospital (JP)
- Suita Municipal Hospital (JP)
- Hiroshima University Hospital (JP)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- Iwakuni Medical Center (JP)
- Aichi Cancer Center (JP)
- Shizuoka General Hospital (JP)
- Nagano Red Cross Hospital (JP)
- Yokohama Municipal Citizen's Hospital (JP)
- Shikoku Cancer Center (JP)
- Asahi General Hospital (JP)
- Aso Iizuka Hospital (JP)
- National Cancer Center Hospital East (JP)
- Osaka International Cancer Institute (JP)
- Kobe City Medical Center General Hospital (JP)
- Sendai Kousei Hospital (JP)
- Niigata University (JP)
- Nippon Medical School (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359241312503
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00